KALOWSKI LEE (CFO and President) sold 2.8% of their position (3.97K shares) of Q32 BIO INC. on the open market
Open‑market sale worth $65.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/27/2026ACC: 0001193125-26-371293
Officer· CFO and President
Since Feb 2026
-3.97K
Net shares
Net seller
$65.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.97K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.97K
Price / share
$16.56
Trade value
$65.78K
% of position
2.8%
8/25/2026
142.44K→138.47K
Total
Net shares
−3.97K
Net value
-$65.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2026 | S · Sale | −3.97K | $16.56 | $65.78K | 2.8% | 142.44K | 138.47K |
| Total | −3.97K | -$65.78K | ||||||
Derivative Transactions0
No derivative transactions reported